InvestorsHub Logo
Followers 18
Posts 417
Boards Moderated 0
Alias Born 10/09/2018

Re: Kpauliukonis post# 21830

Tuesday, 06/04/2019 4:32:08 AM

Tuesday, June 04, 2019 4:32:08 AM

Post# of 43784
Kpauliukonis
While your post has passed almost unnoticed, it should be of utmost importance for those who should think about investing in Cel SCI
I don't know if your questions was inspired from my original ideas regarding HPV prevalence and developing countries SOC
(here : Fosco View on trial Population)
but the answer of your ENT goes exactly where my conclusions go as well
This is all good for the trial outcome
I am not expecting a five years SoC observed OS above 55% in the best case in the blend of patients of this pIII trial
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News